Xiaochun Han

Title: Innovations of Xiaochun Han in Pharmaceutical Chemistry

Introduction

Xiaochun Han is a prominent inventor based in San Jose, California, known for his significant contributions to pharmaceutical chemistry. With a total of 13 patents to his name, he has made remarkable strides in the development of compounds aimed at treating serious health conditions, particularly human immunodeficiency virus (HIV) infections.

Latest Patents

Among his latest patents, Han has developed bridged tricyclic carbamoylpyridone compounds that are disclosed for their pharmaceutical use. These compounds are designed for treating or preventing HIV infection and include various stereoisomers and pharmaceutically acceptable salts. The detailed formula and methods associated with the preparation and use of these compounds are also outlined in his patent. Additionally, he has patented substituted pyridotriazine compounds, which are similarly aimed at treating or preventing HIV infection. This patent includes pharmaceutical compositions and methods for making these compounds.

Career Highlights

Xiaochun Han has worked with notable companies in the pharmaceutical industry, including Gilead Sciences, Inc. and F. Hoffmann-La Roche AG. His work in these organizations has contributed to the advancement of innovative treatments in the field of medicine.

Collaborations

Han has collaborated with several professionals in his field, including Ana Zurisadai Gonzalez Buenrostro and Hong Yang. These collaborations have likely enhanced the research and development of his patented compounds.

Conclusion

Xiaochun Han's innovative work in pharmaceutical chemistry, particularly in the development of compounds for HIV treatment, showcases his significant impact on the field. His patents reflect a commitment to advancing medical science and improving patient outcomes.